|
Recently Approved Documents
Managing and Validating Laboratory Information Systems (AUTO8-A); Reference Leukocyte (WBC) Differential Count (Proportional) and Evaluation of Instrumental Methods (H20-A2); Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria (M11-A7); Performance Standards for Antimicrobial Susceptibility Testing; Seventeenth Informational Supplement (M100-S17)
H20-A2— Reference Leukocyte (WBC) Differential Count (Proportional) and Evaluation of Instrumental Methods; Approved Standard—Second Edition
This document is a reference method for the evaluation of automated differential counters, based on the visual differential count.
Purchase here.
M11-A7— Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Approved Standard—Seventh Edition
This document provides reference methods for the determination of minimal inhibitory concentrations (MICs) of anaerobic bacteria by agar dilution and broth microdilution. THIS DOCUMENT IS COMPLETE WITH TABLES FOR AST OF ANAEROBIC BACTERIA UPDATED FOR 2007.
Updates:
• new QC and interpretive criteria for Moxifloxacin;
• new QC strain Clostridium difficile with QC ranges for various antimicrobial
agents;
• alternative methods for generating an anaerobic environment provided; and
• new antimicrobial agents and QC ranges to test for and report.
Purchase here.
Second Notice
AUTO8-A—Managing and Validating Laboratory Information Systems; Approved Guideline
This document provides guidance for developing a protocol for validation of the laboratory information system (LIS) as well as protocols for assessing the dependability of the LIS when storing, retrieving, and transmitting data.
Purchase here.
M100-S17—Performance Standards for Antimicrobial Susceptibility Testing; Seventeenth Informational Supplement
The latest recommendations for detecting emerging resistance. Includes updated tables from CLSI’s newest disk (M2-A9) susceptibility and MIC (M7-A7) testing standards.
Purchase here.
Our procedures have been designed to ensure that consensus has been achieved when a standard or guideline is published at the approved level. This means that a document has been rigorously reviewed by the authoring subcommittee, the area committee overseeing the project, the Board of Directors, and the medical-testing community that participates in the consensus process by carefully reviewing and commenting on the standard or guideline.
You may automatically receive or select approved-level documents as a member benefit. Find out more about joining CLSI: view membership options and benefits.
[
return to top ]
|
